AzTrials
AzTrials

Prematurity; ExtremeNCT03504215

Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.

A study testing Exercise Intervention in people with Prematurity; Extreme, run by St. Justine's Hospital at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In spite of advances in neonatal intensive care allowing the first generation survivors of extreme prematurity to now reach young adulthood, these individuals present with reduced exercise capacity; a strong predictor of later chronic disease and mortality. Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Prematurity; Extreme
What is being tested?
Exercise Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteCanada
Study dates
2 Mar 2018to 27 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Both groups :
  • Aged between 18-29 years old
  • Less than 120 minutes of exercise per week
  • Willingness to be part of the 14 weeks exercise intervention
  • Preterm group:
  • Born under 29 weeks of gestation
Show all 9Show fewer
  • Term group :
  • Born between 37-41 weeks
  • Appropriate weight fo gestational weight

Who cannot join

  • Pregnancy
  • conditions excludins individual from exercise

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • St. Justine's Hospital

    Montreal, Quebec, H3T1C5

Other trials in Canada

About this study

Official title: Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health

In spite of advances in neonatal intensive care allowing the first generation survivors of extreme prematurity to now reach young adulthood, these individuals present with reduced exercise capacity; a strong predictor of later chronic disease and mortality. The reason why individuals born preterm have exercise limitation remains unclear and may be a consequence of impact of preterm birth and associated neonatal difficulties on the development of organs important for exercise, namely the lungs, the heart, the vessels (which bring blood and oxygen to the muscles) and the muscles. It is well known that exercise benefits overall health in at-risk as well diseased populations. However, whether exercise training can improve fitness in young adults born preterm was not demonstrated and whether the cardiovascular, pulmonary and muscle impairments associated with preterm birth are reversible through exercise intervention in young adulthood is unknown.

Read the detailed description

The investigators postulate that a 14-week exercise intervention will improve exercise capacity in preterm adults, as seen in other at-risk populations, in correlation with measures of vascular health, heart and muscle perfusion and oxygenation, and pulmonary function detected by cutting edge and highly sensitive imaging and circulating biomarkers. These markers are more sensitive to pre-disease changes than traditional health measures, and are largely unexplored in preterm populations.

The investigators will:

  1. Determine whether a 14-week supervised exercise training improves exercise capacity in young adults (18-29 years old) born very preterm at <29 weeks gestational age.
  2. Examine whether improvement in exercise capacity is associated with changes in (a) markers of vascular health including circulating endothelial progenitor cells and microparticles, (b) cardiac perfusion by cutting-edge oxygenation-sensitive cardiovascular magnetic resonance imaging (MRI), (c) lung regional ventilation measured by newly developed hydrogen proton (1H) MRI, (d) muscle oxygenation during exercise.
  3. Compare the response of the above measures to exercise intervention between young adults born very preterm and term controls.
Keywords
extremely preterm, young adults, term, exercise capacity, pulmonary function, muscle oxygenation
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise InterventionOther

    Assigned intervention : 14-week supervised intervention of aerobic and resistance training.

Study groups in NCT03504215
Study groupRoleWhat they receive
young adultsExperimentalBoth young adults born preterm (n=60) and term (n=30) will undergo the exercise intervention.
Receives: Other: Exercise Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of the peak oxygen consumption before and after the physical intervention

    Respiratory exchange ratio (RER) (%)

    Measured: 16 weeks

  2. Measurement of the peak oxygen consumption before and after the physical intervention

    Oxygen uptake (VO2max) (mL/min)

    Measured: 16 weeks

  3. Measurement of the peak oxygen consumption before and after the physical intervention

    Carbon dioxide production (VCO2) (L/min)

    Measured: 16 weeks

  4. Measurement of the peak oxygen consumption before and after the physical intervention

    VO2peak (mL/kg/min)

    Measured: 16 weeks

  5. Measurement of the peak oxygen consumption before and after the physical intervention

    Weight (kg)

    Measured: 16 weeks

  6. Measurement of the peak oxygen consumption before and after the physical intervention

    Height (cm)

    Measured: 16 weeks

  7. Measurement of the peak oxygen consumption before and after the physical intervention

    Age (years)

    Measured: 16 weeks

Secondary outcomes (6)
  1. Cardiac oxygen sensitive MRI (OS-MRI)

    myocardial perfusion in response to CO2 modulation

    Measured: 18 weeks

  2. Lung regional ventilation using a 3D proton MRI ultrashort ecotime

    Parenchyma signal intensity (SI)

    Measured: 1 week

  3. Muscle oxygenation

    Near-infrared spectroscopy (NIRS)

    Measured: 18 weeks

  4. Pulmonary function

    Forced spirometry (FEV1, L)

    Measured: 18 weeks

  5. Pulmonary function

    Forced spirometry (FVC, L)

    Measured: 18 weeks

  6. Pulmonary function

    Forced spirometry (FEF25-75, L/s)

    Measured: 18 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2018
  2. Study start2 Mar 2018
  3. Primary completion18 Jan 2021
  4. Study completion27 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
Group assignments. Both groups are evaluated before and after a 14 week supervised exercise (aerobic and resistance training) intervention.
Masking
None (open label)
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03504215
Sponsor's protocol ID
HAPI Fit Clinical Study
Status last verified
Nov 2022
First submitted
10 Apr 2018
Last updated
3 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Girard-Bock C, Michaud C, Dartora DR, Al-Simaani A, Bastien-Tardif C, Deprez A, Flahault A, Bigras JL, Lapointe A, Du Pont-Thibodeau A, Villeneuve A, Sonea A, Chanane N, Cloutier A, He Y, Mathieu ME, Luu TM, Nuyt AM. Clinical study: Cardiovascular outcomes after a 14-week exercise intervention in young adults born preterm. Pediatr Res. 2026 Jun 3. doi: 10.1038/s41390-026-05130-0. Online ahead of print.

    PubMed 42236922
  • Tardif CB, Mathieu ME, Caru M, Al-Simaani A, Girard-Bock C, Cloutier A, Stickland MK, Nuyt AM, Luu TM. HAPI Fit: An Exercise Intervention to Improve Peak Aerobic Capacity in Young Adults Born Very Preterm. Med Sci Sports Exerc. 2024 Jan 1;56(1):44-52. doi: 10.1249/MSS.0000000000003279. Epub 2023 Aug 30.

    PubMed 37707478

Questions about this trial

What is this clinical trial studying?

A study testing Exercise Intervention in people with Prematurity; Extreme, run by St. Justine's Hospital at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of the peak oxygen consumption before and after the physical intervention (time frame: 16 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03504215, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in